After BLM (5 mg/kg) successfully established the PF rat model, the expression of Smad3, Wnt3a, β-catenin, and GSK-3β were all upregulated in the BLM group (p < 0.01). The gene discussed is WNT3A; the disease is pemphigus foliaceus.